At MedStar Georgetown University Hospital, robots are assisting pharmacists with mixing and delivering some of the most ...

An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for ...

A potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumour cells in ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

Glioblastoma, the most common and lethal form of primary brain cancer, presents daunting challenges. Each year, around 14,500 people in the United States face this aggressive disease. Its invasive ...

Window of opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent ...

An ‘all clear’ at the end of treatment doesn’t necessarily mean the end of cancer. But new UK research aims to eliminate the ...

Zambia and five other low- and middle-income countries will receive free cancer medicines for children through a World Health Organization (WHO) initiative that promises to close the gap in cancer ...

A brain cancer patient has been left "confused" and "shattered" after learning he took chemotherapy drugs needlessly for more ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.

Clinical research by Dana-Farber scientists suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could ...

Mason Conner, a five-year-old previously nonverbal autistic boy from Arizona, finally said his first words just days after he ...